Cargando…

Enigma of the high prevalence of anti-SARS-CoV-2 antibodies in HIV-positive people with no symptoms of COVID-19 in Burkina Faso

The severe acute respiratory syndrome due to the new coronavirus (SARS-CoV-2), responsible for coronavirus disease (COVID-19), has severely tested the global health response capacity, with predictions of a fatality for developing countries. To evaluate the prevalence of anti-SARS-CoV- 2 antibodies i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagna, Tani, Ouedraogo, Paul, Traore, Lassina, Obiri-Yeboah, Dorcas, Yonli, Albert, Tapsoba, Aristide, Tovo, Frida, Sorgho, Abel, Zongo, Laetitia, Nikiema, Ouégo, Ilboudo, Dénise, Belemgnegre, Marius, Nadembega, Christelle W., Ouermi, Djeneba, Djigma, Florencia W., Zohoncon, Théodora M., Poaty, Henriette, Colizzi, Vittorio, Simpore, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202456/ https://www.ncbi.nlm.nih.gov/pubmed/35720802 http://dx.doi.org/10.4081/jphia.2022.1778

Ejemplares similares

Molecular Epidemiology of Human Papillomaviruses, Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium among Female Sex Workers in Burkina Faso: Prevalence, Coinfections and Drug Resistance Genes
por: Tovo, Sessi Frida, et al.
Publicado: (2021)

First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso
por: Dovo, Essi Etonam, et al.
Publicado: (2022)

Prevalence of HPV High-Risk Genotypes in Three Cohorts of Women in Ouagadougou (Burkina Faso)
por: Zohoncon, Theodora M., et al.
Publicado: (2013)

EBV and HHV-6 Circulating Subtypes in People Living with HIV in Burkina Faso, Impact on CD4 T cell count and HIV Viral Load
por: Traore, Lassina, et al.
Publicado: (2017)

KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
por: Tapsoba, Aziz Sidi Aristide, et al.
Publicado: (2022)

World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal
por: Diarra, Birama, et al.
Publicado: (2018)

Molecular diagnosis of cytomegalovirus, Epstein-Barr virus and Herpes virus 6 among blood donors in Ouagadougou, Burkina Faso
por: Traore, Lassina, et al.
Publicado: (2014)

Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns
por: Yelemkoure, Edwige T., et al.
Publicado: (2018)

Diagnostic moléculaire d'helicobacter pylori par PCR chez les patients en consultation gastroentérologique au Centre Médical Saint Camille de Ouagadougou
por: Werme, Karidia, et al.
Publicado: (2015)

Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso
por: Diarra, Birama, et al.
Publicado: (2018)

Molecular Epidemiology of Human Herpes Virus Type 8 Among Patients with Compromised Immune System in Ouagadougou, Burkina Faso
por: Biatougou, Nakougou Moϊ-bohm, et al.
Publicado: (2022)

Seroprevalence, Genotyping, and Monitoring of Hepatitis C Viral Loads in Patients on Antivirals in Burkina Faso
por: Yelemkoure, Edwige T., et al.
Publicado: (2021)

Characterization of High-Risk Oncogenic Human Papillomavirus Genotypes in Histologically Confirmed Ear, Nose and Throat (Ent) Cancers in Burkina Faso
por: Ilboudo, Maïmouna, et al.
Publicado: (2019)

Insights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina Faso
por: Sorgho, Pegdwendé Abel, et al.
Publicado: (2018)

Human immunodeficiency virus type 1 drug resistance in a subset of mothers and their infants receiving antiretroviral treatment in Ouagadougou, Burkina Faso
por: Soubeiga, Serge Théophile, et al.
Publicado: (2018)

Evaluation du traitement antirétroviral chez les femmes enceintes VIH-1 positif, sur la transmission de l'infection de la mère à l'enfant: cas du Centre Médical Saint Camille de Ouagadougou, au Burkina Faso
por: Soubeiga, Serge Theophile, et al.
Publicado: (2015)

Effectiveness of the prevention of mother-to-child transmission of HIV protocol applied at Saint Camille Medical Centre in Ouagadougou, Burkina Faso
por: Theophile Soubeiga, Serge, et al.
Publicado: (2014)

Diagnostic moléculaire du Cytomégalovirus (CMV), de l’herpès virus humain de type 6 (HHV6) et d’Epstein-Barr virus (EBV) par PCR en temps réel chez les femmes enceintes VIH séropositives et séronégatives à Ouagadougou, Burkina Faso
por: Ouedraogo, Alice Rogomenoma, et al.
Publicado: (2016)

Carriage of mutations R462Q (rs 486907) and D541E (rs 627928) of the RNASEL gene and risk factors in patients with prostate cancer in Burkina Faso
por: Kadanga, Essonan, et al.
Publicado: (2022)

Molecular diagnostic of cytomegalovirus, Epstein Barr virus and Herpes virus 6 infections among blood donors by multiplex real-time PCR in Ouagadougou, Burkina Faso
por: Traore, Lassina, et al.
Publicado: (2016)

Seroepidemiology of Hepatitis B and C Viruses in the General Population of Burkina Faso
por: Tao, Issoufou, et al.
Publicado: (2014)

Molecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Burkina Faso: G-6-PD Betica Selma and Santamaria in People with Symptomatic Malaria in Ouagadougou
por: Ouattara, Abdoul Karim, et al.
Publicado: (2016)

Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018
por: Assih, Maléki, et al.
Publicado: (2018)

Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso
por: Traore, Ina Marie Angèle, et al.
Publicado: (2016)

Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso
por: Traoré, Aïda Djé Djénèba, et al.
Publicado: (2022)

Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review
por: Ouattara, Abdoul Karim, et al.
Publicado: (2017)

Mutations in exon 11 (11.1 and 11.2) of the BRCA1 gene and risk factors for breast cancer in Burkina Faso
por: Kiendrebeogo, Isabelle Touwendpoulimdé, et al.
Publicado: (2022)

Genotype characterization of human papillomavirus in women infected and uninfected with HIV in Ouagadougou, Burkina Faso
por: Dkigma, Florencia W, et al.
Publicado: (2012)

Molecular diagnosis of the human immunodeficiency, Hepatitis B and C viruses among blood donors in Lomé (Togo) by multiplex real time PCR
por: Assih, Maléki, et al.
Publicado: (2016)

Mother-to-Children Plasmodium falciparum Asymptomatic Malaria Transmission at Saint Camille Medical Centre in Ouagadougou, Burkina Faso
por: Douamba, Zoenabo, et al.
Publicado: (2014)

Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa
por: Ouedraogo, Rogomenoma Alice, et al.
Publicado: (2018)

Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women
por: Obiri-Yeboah, Dorcas, et al.
Publicado: (2017)

Killer cell immunoglobulin-like receptor alleles influence susceptibility to occult hepatitis B infection in West African population
por: BAZIE, MOMEIYI MICHEE, et al.
Publicado: (2023)

Prevalence of Glu323Lys Mutation of the TIGR/MYOC Gene and Risk Factors amongst Primary Open-angle Glaucoma Patients in Ouagadougou, Burkina Faso
por: Traoré, Lassina, et al.
Publicado: (2023)

A case report of Villar’s nodule in a woman without surgical history
por: Ouédraogo, Nabonswindé Lamoussa Marie, et al.
Publicado: (2018)

Screening of BRCA1 (c.5177_5180delGAAA rs80357867 and c.4986+6T>C rs80358086) and the BRCA2 (c.6445_6446delAT rs80359592) Genes for Breast Cancer Prevention in Burkina Faso
por: Kiendrebeogo, Isabelle T, et al.
Publicado: (2022)

No correlation between the variants of exostosin 2 gene and type 2 diabetes in Burkina Faso population
por: Ouedraogo, Serge Yannick, et al.
Publicado: (2020)

Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
por: Obiri-Yeboah, Dorcas, et al.
Publicado: (2017)

Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
por: Obiri-Yeboah, Dorcas, et al.
Publicado: (2017)

APOBEC3G expression and HIV-1 infection in Burkina Faso
por: Compaore, Tegwinde Rebeca, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h3kbf6amhffv5la0pcvo634e3c